Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard A Fox

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Journal for Immunotherapy of Cancer|April 2, 2026
Bright side of the dark genome: antigens for next-gen cancer vaccinesXiao-Song Wang, Bernard A Fox
European Journal of Gastroenterology & Hepatology|June 11, 2005
The promising future of proteomics in cancer diagnosis and treatmentKevin M Friedman, Bernard A Fox
Current Opinion in Immunology|February 22, 2017
Immunoprofiling as a predictor of patient's response to cancer therapy-promises and challengesDaniel Bethmann, Zipei Feng, Bernard A Fox
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Future of cancer vaccinesHauke Winter, Bernard A Fox, Dominik Rüttinger
Journal of Translational Medicine|January 26, 2012
Supporting the advancement of science: open access publishing and the role of mandatesLisa Phelps, Bernard A Fox, Francesco M Marincola
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacyMichael G LaCelle, Shawn M Jensen, Bernard A Fox
Journal for Immunotherapy of Cancer|May 13, 2025
Asia's emergence in cancer immunotherapy: challenges and opportunitiesYan Li, Joe Yeong, Bernard A Fox, et al.
Oncoimmunology|November 16, 2020
No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international studyPaolo A Ascierto, Francesco M Marincola, Bernard A Fox, et al.
Surgical Oncology Clinics of North America|November 21, 2007
Current immunotherapeutic strategies in lung cancerDominik Rüttinger, Rudolf A Hatz, Karl-Walter Jauch, et al.
International Journal of Cancer|January 22, 2004
Targeting and amplification of immune killing of tumor cells by pro-SmacRui Li, Dominik Rüttinger, Walter Urba, et al.
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Journal for Immunotherapy of Cancer|April 2, 2026
Bright side of the dark genome: antigens for next-gen cancer vaccinesXiao-Song Wang, Bernard A Fox
European Journal of Gastroenterology & Hepatology|June 11, 2005
The promising future of proteomics in cancer diagnosis and treatmentKevin M Friedman, Bernard A Fox
Current Opinion in Immunology|February 22, 2017
Immunoprofiling as a predictor of patient's response to cancer therapy-promises and challengesDaniel Bethmann, Zipei Feng, Bernard A Fox
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Future of cancer vaccinesHauke Winter, Bernard A Fox, Dominik Rüttinger
Journal of Translational Medicine|January 26, 2012
Supporting the advancement of science: open access publishing and the role of mandatesLisa Phelps, Bernard A Fox, Francesco M Marincola
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacyMichael G LaCelle, Shawn M Jensen, Bernard A Fox
Journal for Immunotherapy of Cancer|May 13, 2025
Asia's emergence in cancer immunotherapy: challenges and opportunitiesYan Li, Joe Yeong, Bernard A Fox, et al.
Oncoimmunology|November 16, 2020
No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international studyPaolo A Ascierto, Francesco M Marincola, Bernard A Fox, et al.
Surgical Oncology Clinics of North America|November 21, 2007
Current immunotherapeutic strategies in lung cancerDominik Rüttinger, Rudolf A Hatz, Karl-Walter Jauch, et al.
International Journal of Cancer|January 22, 2004
Targeting and amplification of immune killing of tumor cells by pro-SmacRui Li, Dominik Rüttinger, Walter Urba, et al.
Pageof 16